PhoenixMD Adds Seed Funding to Test Experimental Breast Cancer Drug

Phoenix Molecular Designs, a biotech developing kinase inhibitors to treat cancer, has brought in an undisclosed amount of financing—boosting its total seed funding raised to $12 million.